CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
Authors
Keywords
Hepatocellular carcinoma, Oxaliplatin, CCN2, Id-1, MAPK signaling
Journal
Hepatology International
Volume 13, Issue 4, Pages 440-453
Publisher
Springer Science and Business Media LLC
Online
2019-06-28
DOI
10.1007/s12072-019-09960-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Maintenance of stemness is associated with the interation of LRP6 and heparin-binding protein CCN2 autocrined by hepatocellular carcinoma
- (2017) Qingan Jia et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer
- (2016) Reema Wahdan-Alaswad et al. CELL CYCLE
- Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells
- (2016) Bal Krishan Sharma et al. FASEB JOURNAL
- The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
- (2015) Bénédicte Delire et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)
- (2015) JUN LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Animal and cellular models of hepatocellular carcinoma bone metastasis: establishment and characterisation
- (2015) Rui Hou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
- (2015) Qingan Jia et al. Oncotarget
- VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis
- (2014) D. Georgiadou et al. EJSO
- Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1
- (2014) Yang Bu et al. PLoS One
- Revisiting Oxaliplatin-based Regimens for Advanced Hepatocellular Carcinoma
- (2014) Omar Abdel-Rahman Current Oncology Reports
- LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers
- (2014) Haiyang Yu et al. Nature Communications
- Hepatocellular Carcinoma
- (2013) Andrew J. Page et al. Surgical Oncology Clinics of North America
- Cellular and molecular mechanisms of hepatocellular carcinoma: an update
- (2012) Rajagopal N. Aravalli et al. ARCHIVES OF TOXICOLOGY
- ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21
- (2012) Catherine A. O'Brien et al. CANCER CELL
- Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma
- (2012) Qiong-Zhu Dong et al. HEPATOLOGY
- Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study
- (2012) Aziz Zaanan et al. JOURNAL OF HEPATOLOGY
- A Network of Broadly Expressed HLH Genes Regulates Tissue-Specific Cell Fates
- (2011) Abhishek Bhattacharya et al. CELL
- Potential Prognostic Biomarkers for Bone Metastasis from Hepatocellular Carcinoma
- (2011) Z.-L. Xiang et al. ONCOLOGIST
- Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin
- (2010) Wei Xiong et al. BMC CANCER
- Overexpressed Id-1 is associated with patient prognosis and HBx expression in hepatitis B virus-related hepatocellular carcinoma
- (2010) Rui Ding et al. CANCER BIOLOGY & THERAPY
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
- (2010) Judit Anido et al. CANCER CELL
- Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection
- (2010) Haijun Zhou et al. GUT
- Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma
- (2010) Yu-Hua Xue et al. HEPATOLOGY
- Phase II Study of Oxaliplatin in Patients With Unresectable, Metastatic, or Recurrent Hepatocellular Cancer
- (2009) Y Yen et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- High Levels of Id1 Expression Define B1 Type Adult Neural Stem Cells
- (2009) Hyung-song Nam et al. Cell Stem Cell
- Down-regulation of connective tissue growth factor by inhibition of transforming growth factor β blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma
- (2009) Antonio Mazzocca et al. HEPATOLOGY
- Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma
- (2008) Bing-Sheng Sun et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now